Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-chlorophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C25H18ClF3N2O3S

ClF S, monoclinic, (no. 14), = 9.9087(5) Å, = 21.7843(10) Å, = 10.2512(6) Å, = 94.749(5)°, = 2205.2(2) Å , = 4, ) = 0.0448, ) = 0.1028, = 100 K.

Saved in:
Bibliographic Details
Published inZeitschrift für Kristallographie. New crystal structures Vol. 235; no. 2; pp. 411 - 413
Main Authors Zhou, Yan-Qiu, Hou, Gui-Ge, Meng, Qing-Guo, Hou, Yun
Format Journal Article
LanguageEnglish
Published De Gruyter 01.02.2020
Subjects
1868651
Online AccessGet full text

Cover

More Information
Summary:ClF S, monoclinic, (no. 14), = 9.9087(5) Å, = 21.7843(10) Å, = 10.2512(6) Å, = 94.749(5)°, = 2205.2(2) Å , = 4, ) = 0.0448, ) = 0.1028, = 100 K.
ISSN:1433-7266
2197-4578
DOI:10.1515/ncrs-2019-0716